Welcome to LookChem.com Sign In|Join Free
  • or
1-Methyl-1H-1,2,3-triazole-4-carbaldehyde is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

16681-69-9

Post Buying Request

16681-69-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16681-69-9 Usage

Synthesis Reference(s)

Journal of Heterocyclic Chemistry, 27, p. 2021, 1990 DOI: 10.1002/jhet.5570270733

Check Digit Verification of cas no

The CAS Registry Mumber 16681-69-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,6,8 and 1 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 16681-69:
(7*1)+(6*6)+(5*6)+(4*8)+(3*1)+(2*6)+(1*9)=129
129 % 10 = 9
So 16681-69-9 is a valid CAS Registry Number.

16681-69-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-methyltriazole-4-carbaldehyde

1.2 Other means of identification

Product number -
Other names 1H-1,2,3-TRIAZOLE-4-CARBOXALDEHYDE,1-METHYL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16681-69-9 SDS

16681-69-9Relevant academic research and scientific papers

3-CARBOXYLIC ACID PYRROLES AS NRF2 REGULATORS

-

Page/Page column 71; 72, (2018/07/05)

The present invention relates to 3-carboxylic acid pyrrole compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators. In particular, the compounds of this invention include a compound of Formula (I)

N-ARYL PYRAZOLES AS NRF2 REGULATORS

-

Page/Page column 87, (2018/07/05)

The present invention relates to N-aryl pyrazole compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators. In particular, the compounds of this invention include a compound of Formula (I).

ARYLCYCLOHEXYL PYRAZOLES AS NRF2 REGULATORS

-

Page/Page column 160, (2017/05/07)

The present invention relates to arylcyclohexyl pyrazole compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators.

BIARYL PYRAZOLES AS NRF2 REGULATORS

-

Page/Page column 293, (2017/08/01)

The present invention relates to biaryl pyrazole compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators.

A polymorphism-dependent T1/2 shift of 100 K in a hysteretic spin-crossover complex related to differences in intermolecular weak CH?X hydrogen bonds (X = S vs. S and N)

Hagiwara, Hiroaki,Okada, Shohei

supporting information, p. 815 - 818 (2016/01/12)

A neutral mononuclear iron(ii) complex with a 1,2,3-triazole-containing tetradentate ligand has been obtained as two solvent-free polymorphs. Both polymorphs show hysteretic spin crossover with a polymorphism-dependent T1/2 shift of 100 K that

METHODS OF USING DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY (ADP-RIBOSE)POLYMERASE (PARP)

-

Page/Page column 152, (2011/11/01)

Provided herein are methods of treating cancer comprising administering a topoisomerase inhibitor, temozolomide, or a platin in combination with a Compound of Formula (I) or Formula (II), where the substituents Y, Z, A, B, R1, R2, R3, R4 and R5 are as defined herein.

DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP)

-

Page/Page column 79, (2010/03/02)

A compound having the structure set forth in Formula (I) and Formula (II): wherein the substituents Y, Z, A, B, R1, R2, R3, R4 and R5 are as defined herein. Provided herein are inhibitors of poly(ADP-ribose)polymerase activity. Also described herein are pharmaceutical compositions that include at least one compound described herein and the use of a compound or pharmaceutical composition described herein to treat diseases, disorders and conditions that are ameliorated by the inhibition of PARP activity.

Thermal Rearrangement of 4-Iminomethyl-1,2,3-thiadiazoles

L'abbe, Gerrit,Verbeke, Mikaela,Dehaen, Wim,Toppet, Suzanne

, p. 1719 - 1726 (2007/10/02)

Imines derived from 1,2,3-thiadiazole-4-carbaldehyde 4 rearrange thermally into 1,2,3-triazole-4-thiocarbaldehydes 6 which were trapped with anthracene or 2,3-dimethylbutadiene.In two cases, 1,2,3-thiadiazole-4-thiocarbaldehyde 9 was intercepted as the Di

Molecular Rearrangements of 4-Iminomethyl-1,2,3-Triazoles. Replacement of 1-Aryl Substituents in 1H-1,2,3-Triazole-4-carbaldehydes

L'abbe, Gerrit,Bruynseels, Maria,Delbeke, Pieter,Toppet, Suzanne

, p. 2021 - 2027 (2007/10/02)

The two structural isomers, 4 and 5, of 1-substituted-4-iminomethyl-1,2,3-triazoles are interconvertible when heated in dimethyl sulfoxide at 80 deg C.The equilibrium position depends on the electronic properties of the R-substituent, favoring 5 for R = alkyl, benzyl and anisyl, and 4 for p-chlorophenyl and p-nitrophenyl.An interesting application is the synthesis of 1-alkyl-1,2,3-triazole-4-carbaldehydes from 1-phenyl-1,2,3-triazole-4-carbaldehyde by Scheme I.The hydrazones 4i, j and the oxime 4k do not rearrange due to an unfavorable Z-configuration around the C=N bond, whereas the acyloximino derivative 4m is converted into the nitrile 11.The structures of the products have been fully characterized by 13C nmr spectroscopy and the mechanistic details of the rearrangement are discussed.

Replacement of Aryl by Alkyl in 1-Substituted 1H-1,2,3-Triazole-4-carbaldehydes

L'abbe, Gerrit,Bruynseels, Maria

, p. 1492 - 1493 (2007/10/02)

1-Phenyl-1,2,3-triazole-4-carbaldehyde is readily transformed into 1-alkyl-1,2,3-triazole-4-carbaldehydes by thermal isomerization of the corresponding imines, followed by acid hydrolysis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 16681-69-9